##ANALYSISTYPE=SOMATIC_SINGLESAMPLE
##PIPELINE=megSAP 0.1-1206-g5df0547
##SAMPLE=<ID=GS150344_01,Gender=female,ExternalSampleName=151172,IsTumor=yes,IsFFPE=yes,DiseaseGroup=Neoplasms,DiseaseStatus=Affected>
##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - variant quality (QUAL), depth (DP), allele frequency (AF), mean mapping quality of alternate allele (MQM).
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, ENST number, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=regulatory=Regulatory consequence details.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=1000g=Allele frequency in 1000 genomes project.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD project.
##DESCRIPTION=gnomAD_hom_hemi=Homoyzgous counts and hemizygous counts of gnomAD project (genome data).
##DESCRIPTION=gnomAD_sub=Sub-population allele frequenciens (AFR,AMR,EAS,NFE,SAS) in gnomAD project.
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=Sift=Sift effect prediction and score for each transcript: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen=PolyPhen (humVar) effect prediction and score for each transcript: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=fathmm-MKL=fathmm-MKL score (for coding/non-coding regions). Deleterious threshold > 0.5.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 10-20.
##DESCRIPTION=REVEL=REVEL pathogenicity prediction score. Deleterious threshold > 0.5.
##DESCRIPTION=MaxEntScan=MaxEntScan splicing prediction (reference bases score/alternate bases score).
##DESCRIPTION=GeneSplicer=GeneSplicer splicing prediction (state/type/coordinates/confidence/score).
##DESCRIPTION=dbscSNV=dbscSNV splicing prediction (ADA/RF score).
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=tumor_af=Mutant allele frequency in tumor (Sample GS150344_01).
##DESCRIPTION=tumor_dp=Tumor Depth (Sample GS150344_01).
#chr	start	end	ref	obs	tumor_af	tumor_dp	filter	quality	gene	variant_type	coding_and_splicing	regulatory	OMIM	ClinVar	HGMD	RepeatMasker	dbSNP	1000g	gnomAD	gnomAD_hom_hemi	gnomAD_sub	phyloP	Sift	PolyPhen	fathmm-MKL	CADD	REVEL	MaxEntScan	GeneSplicer	dbscSNV	COSMIC
chr13	32911888	32911888	A	G	0.9933	149		QUAL=4875	BRCA2	synonymous	BRCA2:ENST00000380152:synonymous_variant:LOW:exon11/27:c.3396A>G:p.Lys1132=:,BRCA2:ENST00000544455:synonymous_variant:LOW:exon11/28:c.3396A>G:p.Lys1132=:		600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555/Fanconi anemia,complementation group D1,605724/Prostate cancer,176807/Breast cancer,male,susceptibility to,114480/Wilms tumor,194070/Medulloblastoma,155255/Glioblastoma 3,613029/Pancreatic cancer 2,613347];	126010 [benign DISEASE=Fanconi anemia,Hereditary cancer-predisposing syndrome,Familial cancer of breast,Hereditary breast and ovarian cancer syndrome,Breast-ovarian cancer, familial 2,not specified,not provided];			rs1801406	0.2668	0.2984	1425,	0.2277,0.2127,0.3820,0.3087,0.2994	0.2130			0.49,0.90	0.34					COSM4415776
chr13	32913055	32913055	A	G	1.0000	169		QUAL=5583	BRCA2	synonymous	BRCA2:ENST00000380152:synonymous_variant:LOW:exon11/27:c.4563A>G:p.Leu1521=:PF00634,BRCA2:ENST00000544455:synonymous_variant:LOW:exon11/28:c.4563A>G:p.Leu1521=:PF00634		600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555/Fanconi anemia,complementation group D1,605724/Prostate cancer,176807/Breast cancer,male,susceptibility to,114480/Wilms tumor,194070/Medulloblastoma,155255/Glioblastoma 3,613029/Pancreatic cancer 2,613347];	132779 [benign DISEASE=Fanconi anemia,Hereditary cancer-predisposing syndrome,Familial cancer of breast,Hereditary breast and ovarian cancer syndrome,Breast-ovarian cancer, familial 2,not specified,not provided];			rs206075		0.9945	14867,	0.9252,0.9956,0.9999,0.9996,0.9999	0.0710			0.00,0.27	0.03					
chr13	32915005	32915005	G	C	1.0000	102		QUAL=3321	BRCA2	synonymous	BRCA2:ENST00000380152:synonymous_variant:LOW:exon11/27:c.6513G>C:p.Val2171=:,BRCA2:ENST00000544455:synonymous_variant:LOW:exon11/28:c.6513G>C:p.Val2171=:		600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555/Fanconi anemia,complementation group D1,605724/Prostate cancer,176807/Breast cancer,male,susceptibility to,114480/Wilms tumor,194070/Medulloblastoma,155255/Glioblastoma 3,613029/Pancreatic cancer 2,613347];	132780 [benign DISEASE=Fanconi anemia,Hereditary cancer-predisposing syndrome,Familial cancer of breast,Hereditary breast and ovarian cancer syndrome,Breast-ovarian cancer, familial 2,not specified,not provided];			rs206076		0.9943	14873,	0.9251,0.9955,0.9999,0.9995,0.9999	-0.8750			0.02,0.13	-0.45					COSM4147690
chr13	32929387	32929387	T	C	1.0000	123		QUAL=4062	BRCA2	missense	BRCA2:ENST00000380152:missense_variant:MODERATE:exon14/27:c.7397T>C:p.Val2466Ala:,BRCA2:ENST00000544455:missense_variant:MODERATE:exon14/28:c.7397T>C:p.Val2466Ala:		600185 [BRCA2 (confirmed) Breast-ovarian cancer,familial,2,612555/Fanconi anemia,complementation group D1,605724/Prostate cancer,176807/Breast cancer,male,susceptibility to,114480/Wilms tumor,194070/Medulloblastoma,155255/Glioblastoma 3,613029/Pancreatic cancer 2,613347];	133738 [benign DISEASE=Ductal breast carcinoma,not specified];			rs169547	0.9758	0.9950	14936,	0.9322,0.9958,0.9999,0.9997,0.9999	2.3520	T(0.11),T(0.11)	B(0.88),B(0.88)	0.00,0.10	0.86	0.09				
chr17	41226536	41226536	G	T	0.4902	102		QUAL=1291	BRCA1	stop_gained&splice_region,intron,splice_region&5'UTR	BRCA1:ENST00000309486:stop_gained&splice_region_variant:HIGH:exon13/22:c.3599C>A:p.Ser1200Ter:,BRCA1:ENST00000346315:intron_variant:MODIFIER:exon12/18:c.4357+7885C>A::,BRCA1:ENST00000351666:stop_gained&splice_region_variant:HIGH:exon10/19:c.938C>A:p.Ser313Ter:,BRCA1:ENST00000352993:stop_gained&splice_region_variant:HIGH:exon13/22:c.1061C>A:p.Ser354Ter:,BRCA1:ENST00000354071:intron_variant:MODIFIER:exon12/17:c.4357+7885C>A::,BRCA1:ENST00000357654:stop_gained&splice_region_variant:HIGH:exon14/23:c.4487C>A:p.Ser1496Ter:,BRCA1:ENST00000468300:stop_gained&splice_region_variant:HIGH:exon14/22:c.1175C>A:p.Ser392Ter:,BRCA1:ENST00000471181:stop_gained&splice_region_variant:HIGH:exon15/24:c.4550C>A:p.Ser1517Ter:,BRCA1:ENST00000491747:stop_gained&splice_region_variant:HIGH:exon14/23:c.1175C>A:p.Ser392Ter:,BRCA1:ENST00000493795:stop_gained&splice_region_variant:HIGH:exon13/22:c.4346C>A:p.Ser1449Ter:,BRCA1:ENST00000586385:intron_variant:MODIFIER:exon1/7:c.5-10568C>A::,BRCA1:ENST00000591534:splice_region_variant&5_prime_UTR_variant:LOW:exon2/11:c.-41C>A::,BRCA1:ENST00000591849:intron_variant:MODIFIER:exon1/4:c.-98-24329C>A::		113705 [BRCA1 (confirmed) Breast-ovarian cancer,familial,1,604370/Pancreatic cancer,susceptibility to,4,614320/Fanconi anemia,complementation group S,617883];	55215 [pathogenic DISEASE=Familial cancer of breast,Breast-ovarian cancer, familial 1];	CM1719097 [CLASS=DM MUT=ALT PHEN="Ovarian cancer" GENE=BRCA1];		rs80356953					1.1860			0.58,0.53	5.76		12.00>11.67			
